Silicon Laboratories, Inc.

Silicon Laboratories, Inc.

221.65
USD
+0.22
(+0.10%)
-0.61EPS
7.40BMarket Cap
Feb 03Next Earn

Total Valuation

USD

As of September 30, 2026, Silicon Laboratories, Inc. carries a market capitalization of 7.40B, placing it among publicly traded companies globally. Its enterprise value stands at 6.96B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap7.40B
Enterprise Value6.96B

Important Dates

Silicon Laboratories, Inc.'s next confirmed earnings release is scheduled for February 3, 2027.

Earnings Date2/3/2027

Share Statistics

As of September 30, 2026, Silicon Laboratories, Inc. has 33.38M shares outstanding.

Shares Outstanding33.38M

Valuation Ratios

These figures are as of September 30, 2026. The price-to-sales ratio is 8.15, and the price-to-book ratio stands at 6.57.

PS Ratio8.15
PB Ratio6.57
P/TBV Ratio10.10
P/FCF Ratio1,037.02
P/OCF Ratio161.10

Enterprise Valuation

As of September 30, 2026, Silicon Laboratories, Inc. trades at an EV/EBITDA multiple of 680.03 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 7.72 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 6.96B versus a market cap of 7.40B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales7.72
EV / EBITDA680.03

Financial Position

As of September 30, 2026, Silicon Laboratories, Inc. maintains a current ratio of 4.60, meaning it holds 4.6x the short-term assets needed to cover near-term liabilities.

Current Ratio4.60
Quick Ratio3.30
Interest Coverage11.08

Financial Efficiency

USD

Over the twelve months ended September 30, 2026, Silicon Laboratories, Inc. posted a negative return on equity (ROE) of -1.85, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -1.57, reflecting losses generated across the asset base. The company generates approximately 466,729.02 in revenue per employee across its workforce of 1,930.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.23 indicates how many times Silicon Laboratories, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)-1.85
Return on Assets (ROA)-1.57
Revenue Per Employee466,729.02
Employee Count1,930.00
Inventory Turnover3.23

Taxes

USD

Over the twelve months ended September 30, 2026, Silicon Laboratories, Inc. recorded 8.58M in income tax expense. The company reported a pretax loss of -11.74M and -20.32M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax8.58M

Stock Price Statistics

USD

As of the close on November 16, 2026, Silicon Laboratories, Inc.'s stock has gained approximately 81.84% over the past 52 weeks. The 50-day moving average sits at 221.33, while the 200-day moving average is 215.07.

52-Week Price Change81.84%
50-Day Moving Average221.33
200-Day Moving Average215.07

Income Statement

USD

Over the twelve months ended September 30, 2026, Silicon Laboratories, Inc. generated 900.79M in revenue and converted that into -20.32M in net income, yielding earnings per share of -0.61. EBITDA reached 10.23M, while operating income came in at -23.05M.

Revenue900.79M
Gross Profit552.33M
Operating Income-23.05M
Pretax Income-11.74M
Net Income-20.32M
EBITDA10.23M
EBIT-23.05M
Earnings Per Share (EPS)-0.61

Balance Sheet

USD

These figures are as of September 30, 2026. Total book value stands at 1.13B, with working capital of 567.11M providing operational flexibility.

Cash & Cash Equivalents439.84M
Net Debt-423.01M
Equity (Book Value)1.13B
Book Value Per Share33.71
Working Capital567.11M

Cash Flow

USD

Silicon Laboratories, Inc. produced 45.55M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -38.45M in capital expenditures, free cash flow totaled 7.10M - equivalent to 0.21 per share.

Operating Cash Flow45.55M
Capital Expenditures-38.45M
Free Cash Flow7.10M
FCF Per Share0.21

Margins

Over the twelve months ended September 30, 2026, Silicon Laboratories, Inc. posted a gross margin of 61.32, reflecting its pricing power and cost economics. The operating margin of -2.56 and net profit margin of -2.26 provide insight into operational efficiency.

Gross Margin61.32
Operating Margin-2.56
Pretax Margin-1.30
Profit Margin-2.26
EBITDA Margin1.14

Dividends & Yields

These figures cover the twelve months ended September 30, 2026. Free cash flow yield stands at 0.10, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 0.21, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Silicon Laboratories, Inc. shareholders.

Shareholder Yield0.21
FCF Yield0.10

Scores

As of September 30, 2026, Silicon Laboratories, Inc. has an Altman Z-Score of 24.02, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score24.02